Global trends in the distribution of Candida species causing candidemia.

PubWeight™: 2.10‹?› | Rank: Top 2%

🔗 View Article (PMID 24506442)

Published in Clin Microbiol Infect on March 06, 2014

Authors

J Guinea1

Author Affiliations

1: Clinical Microbiology and Infectious Diseases Department, Hospital General Universitario Gregorio Marañón, Universidad Complutense de Madrid, Madrid, Spain; Instituto de Investigación Sanitaria Gregorio Marañón, Madrid, Spain; CIBER de Enfermedades Respiratorias (CIBER RES CB06/06/0058), Madrid, Spain; Medicine Department, School of Medicine, Universidad Complutense de Madrid, Madrid, Spain.

Articles citing this

Antifungal resistance to fluconazole and echinocandins is not emerging in yeast isolates causing fungemia in a Spanish tertiary care center. Antimicrob Agents Chemother (2014) 0.91

Diagnosis and management of invasive candidiasis in the ICU: an updated approach to an old enemy. Crit Care (2016) 0.91

Candida glabrata candidemia. Indian J Crit Care Med (2015) 0.89

Controlled Evaluation of the New BacT/Alert Virtuo Blood Culture System for Detection and Time to Detection of Bacteria and Yeasts. J Clin Microbiol (2016) 0.87

Antifungal susceptibility profiles of bloodstream yeast isolates by Sensititre YeastOne over nine years at a large Italian teaching hospital. Antimicrob Agents Chemother (2015) 0.86

Kinetic studies of Candida parapsilosis phagocytosis by macrophages and detection of intracellular survival mechanisms. Front Microbiol (2014) 0.85

Set of classical PCRs for detection of mutations in Candida glabrata FKS genes linked with echinocandin resistance. J Clin Microbiol (2014) 0.84

Delinking CARD9 and IL-17: CARD9 Protects against Candida tropicalis Infection through a TNF-α-Dependent, IL-17-Independent Mechanism. J Immunol (2015) 0.84

Rapid Development of Candida krusei Echinocandin Resistance during Caspofungin Therapy. Antimicrob Agents Chemother (2015) 0.80

Are the Conventional Commercial Yeast Identification Methods Still Helpful in the Era of New Clinical Microbiology Diagnostics? A Meta-Analysis of Their Accuracy. J Clin Microbiol (2015) 0.80

Photodynamic therapy of oral Candida infection in a mouse model. J Photochem Photobiol B (2016) 0.80

Investigation of an unrecognized large-scale outbreak of Candida parapsilosis sensu stricto fungaemia in a tertiary-care hospital in China. Sci Rep (2016) 0.78

Different Candida parapsilosis clinical isolates and lipase deficient strain trigger an altered cellular immune response. Front Microbiol (2015) 0.78

Alginate oligosaccharides inhibit fungal cell growth and potentiate the activity of antifungals against Candida and Aspergillus spp. PLoS One (2014) 0.78

A Novel Hybrid Iron Regulation Network Combines Features from Pathogenic and Nonpathogenic Yeasts. MBio (2016) 0.77

Binary Interactions of Antagonistic Bacteria with Candida albicans Under Aerobic and Anaerobic Conditions. Microb Ecol (2015) 0.77

How Chemotherapy Increases the Risk of Systemic Candidiasis in Cancer Patients: Current Paradigm and Future Directions. Pathogens (2016) 0.77

Distinct Expression Levels of ALS, LIP, and SAP Genes in Candida tropicalis with Diverse Virulent Activities. Front Microbiol (2016) 0.77

New strategic insights into managing fungal biofilms. Front Microbiol (2015) 0.76

Filamentation protects Candida albicans from amphotericin B-induced programmed cell death via a mechanism involving the yeast metacaspase, MCA1. Microb Cell (2016) 0.76

Rapid detection of FKS-associated echinocandin resistance in Candida glabrata. Antimicrob Agents Chemother (2016) 0.76

A multi-centric Study of Candida bloodstream infection in Lima-Callao, Peru: Species distribution, antifungal resistance and clinical outcomes. PLoS One (2017) 0.75

Effects of human blood red cells on the haemolytic capability of clinical isolates of Candida tropicalis. J Biomed Sci (2015) 0.75

Variable incidence of candidemia in patients admitted to ICUs or medical wards of large tertiary-care Italian hospitals. Clin Microbiol Infect (2015) 0.75

Fluconazole and Voriconazole Resistance in Candida parapsilosis Is Conferred by Gain-of-Function Mutations in MRR1 Transcription Factor Gene. Antimicrob Agents Chemother (2015) 0.75

Dictyostelium discoideum as a Novel Host System to Study the Interaction between Phagocytes and Yeasts. Front Microbiol (2016) 0.75

Candida parapsilosis: an emerging pathogen developing its own identity. Virulence (2015) 0.75

Draft Genome Sequences of Candida glabrata Isolates 1A, 1B, 2A, 2B, 3A, and 3B. Genome Announc (2017) 0.75

Candidemia in a major regional tertiary referral hospital - epidemiology, practice patterns and outcomes. Antimicrob Resist Infect Control (2017) 0.75

Risk factors for Candida parapsilosis bloodstream infection in a neonatal intensive care unit: a case-control study. Ital J Pediatr (2017) 0.75

The Fungal Pathogen Candida glabrata Does Not Depend on Surface Ferric Reductases for Iron Acquisition. Front Microbiol (2017) 0.75

Functional analysis of selected deletion mutants in Candida glabrata under hypoxia. 3 Biotech (2017) 0.75

Candida guilliermondii complex is characterized by high antifungal resistance but low mortality: a report on 22 cases of candidemia. Antimicrob Agents Chemother (2017) 0.75

In vitro inhibitory activities of magnolol against Candida spp. Drug Des Devel Ther (2017) 0.75

Molecular Epidemiology and Antifungal Susceptibility of Candida glabrata in China (August 2009 to July 2014): A Multi-Center Study. Front Microbiol (2017) 0.75

Distribution and antifungal susceptibility of yeasts isolates from intensive care unit patients. Folia Microbiol (Praha) (2017) 0.75

Survival, Persistence, and Isolation of the Emerging Multidrug-Resistant Pathogenic Yeast Candida auris on a Plastic Healthcare Surface. J Clin Microbiol (2017) 0.75

Population structure and molecular genetic characterization of clinical Candida tropicalis isolates from a tertiary-care hospital in Kuwait reveal infections with unique strains. PLoS One (2017) 0.75